Rho protein-mediated changes in the structure of the actin cytoskeleton regulate human inducible NO synthase gene expression

Experimental Cell Research

Volumn 287, Issue 1, 2003, Pages 106-115

  Witteck, Andrea ^a   Yao, Ying ^a   Fechir, Marcel ^a   Foörstermann, Ulrich ^a   Kleinert, Hartmut ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Actin cytoskeleton; Expression; Human inducible NO synthase; mRNA stability; Promoter activity

Indexed keywords

ACTIN; ISOPROTEIN; MESSENGER RNA; NITRIC OXIDE SYNTHASE; RHO FACTOR; SERUM RESPONSE FACTOR; TRANSCRIPTION FACTOR;

ARTICLE; CYTOSKELETON; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN STRUCTURE;

CLOSTRIDIUM DIFFICILE;

EID: 0038205328     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-4827(03)00129-0     Document Type: Article

References (40)

1. Kleinert H., Boissel J.P., Schwarz P.M., Förstermann U. Regulation of the expression of nitric oxide synthase isoforms. Ignarro L.J. Nitric Oxide Biology and Pathobiology . 2000;105-128 Academic Press, New York.
2. Stallmeyer B., Kampfer H., Kolb N., Pfeilschifter J., Frank S. The function of nitric oxide in wound repair inhibition of inducible nitric oxide-synthase severely impairs wound reepithelialization . J. Invest. Dermatol. 113:1999;1090-1098.
3. Kim Y.M., deVera M.E., Watkins S.C., Billiar T.R. Nitric oxide protects cultured rat hepatocytes from tumor necrosis factor-α-induced apoptosis by inducing heat shock protein 70 expression. J. Biol. Chem. 272:1997;1402-1411.
4. Kröncke K.D., Fehsel K., Kolb-Bachofen V. Inducible nitric oxide synthase in human diseases. Clin. Exp. Immunol. 113:1998;147-156.
5. Kleinert H., Wallerath T., Fritz G., Ihrig-Biedert I., Rodriguez-Pascual F., Geller D.A., Förstermann U. Cytokine induction of NO synthase II in human DLD-1 cells roles of the JAK-STAT, AP-1 and NF-κB-signaling pathways . Br. J. Pharmacol. 125:1998;193-201.
6. Vodovotz Y., Bogdan C., Paik J., Xie Q.W., Nathan C. Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor-β1. J. Exp. Med. 178:1993;605-613.
7. Rodriguez-Pascual F., Hausding M., Ihrig-Biedert I., Furneaux H., Levy A.P., Forstermann U., Kleinert H. Complex contribution of the 3′-untranslated region to the expressional regulation of the human inducible nitric-oxide synthase gene involvement of the RNA-binding protein HuR . J. Biol. Chem. 275:2000;26040-26049.
8. Takai Y., Sasaki T., Matozaki T. Small GTP-binding proteins. Physiol. Rev. 81:2001;153-208.
9. Ishizaki T., Uehata M., Tamechika I., Keel J., Nonomura K., Maekawa M., Narumiya S. Pharmacological properties of Y-27632, a specific inhibitor of rho-associated kinases. Mol. Pharmacol. 57:2000;976-983.
10. Sotiropoulos A., Gineitis D., Copeland J., Treisman R. Signal-regulated activation of serum response factor is mediated by changes in actin dynamics. Cell. 98:1999;159-169.
11. Mack C.P., Somlyo A.V., Hautmann M., Somlyo A.P., Owens G.K. Smooth muscle differentiation marker gene expression is regulated by RhoA-mediated actin polymerization. J. Biol. Chem. 276:2001;341-347.
12. Wei L., Wang L., Carson J.A., Agan J.E., Imanaka-Yoshida K., Schwartz R.J. β1 integrin and organized actin filaments facilitate cardiomyocyte-specific RhoA-dependent activation of the skeletal alpha-actin promoter. FASEB J. 15:2001;785-796.
13. Denhardt D.T. Signal-transducing protein phosphorylation cascades mediated by Ras/Rho proteins in the mammalian cell the potential for multiplex signalling . Biochem. J. 318:1996;729-747.
14. Hausding M., Witteck A., Rodriguez-Pascual F., von Eichel-Streiber C., Forstermann U., Kleinert H. Inhibition of small G proteins of the rho family by statins or Clostridium difficile toxin B enhances cytokine-mediated induction of NO synthase II. Br. J. Pharmacol. 131:2000;553-561.
15. Edgell C.J., McDonald C.C., Graham J.B. Permanent cell line expressing human factor VIII-related antigen established by hybridization. Proc. Natl. Acad. Sci. USA. 80:1983;3734-3737.
16. Nussler A.K., Vergani G., Gollin S.M., Dorko K., Morris S.M. Jr., Demetris A.J., Nomoto M., Beger H.G., Strom S.C. Isolation and characterization of a human hepatic epithelial-like cell line (AKN-1) from a normal liver. In Vitro Cell Dev. Biol. Anim. 35:1999;190-197.
17. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
18. Kleinert H., Euchenhofer C., Ihrig-Biedert I., Förstermann U. Glucocorticoids inhibit the induction of nitric oxide synthase II by down-regulating cytokine-induced activity of transcription factor nuclear factor-κB. Mol. Pharmacol. 49:1996;15-21.
19. de Vera M.E., Shapiro R.A., Nüssler A.K., Mudgett J.S., Simmons R.L., Morris S.M., Billiar T.R., Geller D.A. Transcriptional regulation of human inducible nitric oxide synthase (NOS2)gene by cytokines initial analysis of the human NOS2 promoter . Proc. Natl. Acad. Sci. USA. 93:1996;1054-1059.
20. von Eichel-Streiber C., Boquet P., Sauerborn M., Thelestam M. Large clostridial cytotoxins a family of glycosyltransferases modifying small GTP-binding proteins . Trends Microbiol. 4:1996;375-382.
21. Chen H., Ikeda U., Shimpo M., Ikeda M., Minota S., Shimada K. Fluvastatin upregulates inducible nitric oxide synthase expression in cytokine-stimulated vascular smooth muscle cells. Hypertension. 36:2000;923-928.
22. Muniyappa R., Xu R., Ram J.L., Sowers J.R. Inhibition of Rho protein stimulates iNOS expression in rat vascular smooth muscle cells. Am. J. Physiol. Heart Circ. Physiol. 278:2000;H1762-H1768.
23. Ikeda U., Shimpo M., Ikeda M., Minota S., Shimada K. Lipophilic statins augment inducible nitric oxide synthase expression in cytokine-stimulated cardiac myocytes. J. Cardiovasc. Pharmacol. 38:2001;69-77.
24. Ting-Beall H.P., Lee A.S., Hochmuth R.M. Effect of cytochalasin D on the mechanical properties and morphology of passive human neutrophils. Ann. Biomed. Eng. 23:1995;666-671.
25. Coue M., Brenner S.L., Spector I., Korn E.D. Inhibition of actin polymerization by latrunculin A. FEBS Lett. 213:1987;316-318.
26. Sympson C.J., Singleton D., Geoghegan T.E. Cytochalasin D-induced actin gene expression in murine erythroleukemia cells. Exp. Cell Res. 205:1993;225-231.
27. Bubb M.R., Senderowicz A.M., Sausville E.A., Duncan K.L., Korn E.D. Jasplakinolide, a cytotoxic natural product, induces actin polymerization and competitively inhibits the binding of phalloidin to F-actin. J. Biol. Chem. 269:1994;14869-14871.
28. Senderowicz A.M., Kaur G., Sainz E., Laing C., Inman W.D., Rodriguez J., Crews P., Malspeis L., Grever M.R., Sausville E.A. Jasplakinolide's inhibition of the growth of prostate carcinoma cells in vitro with disruption of the actin cytoskeleton. J. Natl. Cancer Inst. 87:1995;46-51.
29. Bubb M.R., Spector I., Beyer B.B., Fosen K.M. Effects of jasplakinolide on the kinetics of actin polymerization an explanation for certain in vivo observations . J. Biol. Chem. 275:2000;5163-5170.
30. Zeng C., Morrison A.R. Disruption of the actin cytoskeleton regulates cytokine-induced iNOS expression. Am. J. Physiol. Cell Physiol. 281:2001;C932-C940.
31. Henics T. Microfilament-dependent modulation of cytoplasmic protein binding to TNFalpha mRNA AU-rich instability element in human lymphoid cells. Cell Biol. Int. 23:1999;561-570.
32. Zambetti G., Ramsey-Ewing A., Bortell R., Stein G., Stein J. Disruption of the cytoskeleton with cytochalasin D induces c-fos gene expression. Exp. Cell Res. 192:1991;93-101.
33. Lyubimova A., Bershadsky A.D., Ben-Ze'ev A. Autoregulation of actin synthesis requires the 3′-UTR of actin mRNA and protects cells from actin overproduction. J. Cell Biochem. 76:1999;1-12.
34. Rajotte D., Sadowski H.B., Haman A., Gopalbhai K., Meloche S., Liu L., Krystal G., Hoang T. Contribution of both STAT and SRF/TCF to c-fos promoter activation by granulocyte-macrophage colony-stimulating factor. Blood. 88:1996;2906-2916.
35. Wang Y., Prywes R. Activation of the c-fos enhancer by the erk MAP kinase pathway through two sequence elements the c-fos AP-1 and p62TCF sites . Oncogene. 19:2000;1379-1385.
36. Marinissen M.J., Chiariello M., Gutkind J.S. Regulation of gene expression by the small GTPase Rho through the ERK6 (p38 gamma) MAP kinase pathway. Genes Dev. 15:2001;535-553.
37. Pance A., Chantome A., Reveneau S., Bentrari F., Jeannin J.F. A repressor in the proximal human inducible nitric oxide synthase promoter modulates transcriptional activation. FASEB J. 16:2002;631-633.
38. Kizaki T., Suzuki K., Hitomi Y., Iwabuchi K., Onoe K., Haga S., Ishida H., Ookawara T., Ohno H. Negative regulation of LPS-stimulated expression of inducible nitric oxide synthase by AP-1 in macrophage cell line J774A.1. Biochem. Biophys. Res. Commun. 289:2001;1031-1038.
39. Henics T., Nagy E., Szekeres-Bartho J. Interaction of AU-rich sequence binding proteins with actin possible involvement of the actin cytoskeleton in lymphokine mRNA turnover . J. Cell Physiol. 173:1997;19-27.
40. Sirenko O.I., Lofquist A.K., DeMaria C.T., Morris J.S., Brewer G., Haskill J.S. Adhesion-dependent regulation of an A + U-rich element-binding activity associated with AUF1. Mol. Cell Biol. 17:1997;3898-3906.